ALPHAHELIX MOL.DIAGN. SK1 (4MB) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.030x

Based on the latest financial reports, ALPHAHELIX MOL.DIAGN. SK1 (4MB) has a cash flow conversion efficiency ratio of 0.030x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€202.00K ≈ $236.16K USD) by net assets (€6.65 Million ≈ $7.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ALPHAHELIX MOL.DIAGN. SK1 (4MB) market capitalisation for the company's overall valuation and market capitalisation.

ALPHAHELIX MOL.DIAGN. SK1 - Cash Flow Conversion Efficiency Trend (2022–2025)

This chart illustrates how ALPHAHELIX MOL.DIAGN. SK1's cash flow conversion efficiency has evolved over time, based on yearly financial data.

ALPHAHELIX MOL.DIAGN. SK1 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ALPHAHELIX MOL.DIAGN. SK1 ranked by their cash flow conversion efficiency. Explore cash flow quality index of ALPHAHELIX MOL.DIAGN. SK1 to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Migo Opportunities Trust PLC LSE:MIGO	-0.009x
Nicolas Miguet et Associes SA PA:MLNMA	N/A
GenixPharmaceucticals Corporation V:GENX	0.011x
Intercede Group LSE:IGP	0.100x
Enersize Oy ST:ENERS	0.057x
Spectra Systems Corp LSE:SPSY	0.210x
Future Enterprises Limited NSE:FELDVR	-0.222x
GIGLIO GROUP S.P.A. O.N. F:5JR	N/A

Annual Cash Flow Conversion Efficiency for ALPHAHELIX MOL.DIAGN. SK1 (2022–2025)

The table below shows the annual cash flow conversion efficiency of ALPHAHELIX MOL.DIAGN. SK1 from 2022 to 2025. View ALPHAHELIX MOL.DIAGN. SK1 (4MB) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€637.18K ≈ $744.93K	€820.45K ≈ $959.19K	1.288x	+220.54%
2024-12-31	€4.18 Million ≈ $4.88 Million	€-4.46 Million ≈ $-5.22 Million	-1.068x	-104.27%
2023-12-31	€10.41 Million ≈ $12.18 Million	€-5.45 Million ≈ $-6.37 Million	-0.523x	-462.81%
2022-12-31	€19.89 Million ≈ $23.25 Million	€2.87 Million ≈ $3.35 Million	0.144x	--

About ALPHAHELIX MOL.DIAGN. SK1

F:4MB Germany Diagnostics & Research

Market Cap

$879.62K

€752.39K EUR

Market Cap Rank

#30775 Global

#2694 in Germany

Share Price

€0.01

Change (1 day)

-18.52%

52-Week Range

€0.01 - €0.03

All Time High

€0.32